<?xml version="1.0" encoding="ASCII"?>
<!DOCTYPE article PUBLIC "-//BEILSTEIN-INSTITUT//DTD Journal Article DTD v0.3 20080808//EN" "http://www.beilstein-journals.org/bjoc/content/xml/journalarticle.dtd">
<article locale="en" publisher="Beilstein-Institut" public-id="1860-5397-1-12" type="full-research-paper" journal="Beilstein Journal of Organic Chemistry" year="2005" volume="1" article="12" issn="1860-5397">
<author first-name="Olivia" last-name="Andriuzzi" email="Olivia.Andriuzzi@univ-paris5.fr" affiliations="a1"/>
<author first-name="Christine" last-name="Gravier-Pelletier" email="Christine.Gravier-Pelletier@univ-paris5.fr" affiliations="a1" corresponding-author="yes"/>
<author first-name="Gildas" last-name="Bertho" email="Gildas.Bertho@univ-paris5.fr" affiliations="a1"/>
<author first-name="Thierry" last-name="Prang&#233;" email="Thierry.Prange@univ-paris5.fr" affiliations="a2"/>
<author first-name="Yves" last-name="Le Merrer" email="Yves.Le-Merrer@univ-paris5.fr" affiliations="a1" corresponding-author="yes"/>
<affiliation id="a1">Universit&#233; Paris Descartes, UMR 8601 CNRS, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, 45 rue des Saints-P&#232;res, 75270 Paris Cedex 06, France</affiliation>
<affiliation id="a2">Universit&#233; Paris Descartes, UMR 8015 CNRS, Laboratoire de Cristallographie et RMN Biologiques, 4 avenue de l'Observatoire, 75270 Paris Cedex 06, France</affiliation>
<submission-date day="22" month="7" year="2005"/>
<acceptance-date day="7" month="10" year="2005"/>
<publication-date day="7" month="10" year="2005"/>
<title>
<chunk>Synthesis and glycosidase inhibitory activity of new hexa-substituted C8-glycomimetics</chunk>
</title>
<abstract-section>
<abstract-subsection>
<title>
<chunk>Background</chunk>
</title>
<paragraph>
<chunk>Glycosidases are involved in several metabolic pathways and the development of inhibitors is an important challenge towards the treatment of diseases, such as diabetes, cancer and viral infections including AIDS. Thus, inhibition of intestinal &#945;-glucosidases can be used to treat diabetes through the lowering of blood glucose levels, and &#945;-glucosidase inhibitors are being marketed against type 2 (non-insulinodependent </chunk>
<chunk italic="yes">mellitus</chunk>
<chunk>) diabetes (</chunk>
<chunk italic="yes">i.e</chunk>
<chunk>.: Glyset</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> or Diastabol</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>, Basen</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> and Glucor</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> or Precose</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>).</chunk>
</paragraph>
</abstract-subsection>
<abstract-subsection>
<title>
<chunk>Results</chunk>
</title>
<paragraph>
<chunk>In that context, new C8-carbasugars and related aminocyclitols have been targeted in order to study the effect of the enhanced flexibility and of the new spatial distribution displayed by these structures on their adaptability in the active site of the enzymes. The synthesis of these new C8-glycomimetics is described from enantiomerically pure C</chunk>
<chunk subscript="yes">2</chunk>
<chunk>-symmetrical polyhydroxylated cyclooctenes. Their obtention notably involved a </chunk>
<chunk italic="yes">syn</chunk>
<chunk>-dihydroxylation, and more extended functionalization through formation of a </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-cyclic sulfate followed by amination and subsequent reductive amination. This strategy involving the nucleophilic opening of a </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-cyclic sulfate by sodium azide is to our knowledge the first example in C8-series. It revealead to be an efficient alternative to the nucleoplilic opening of an epoxide moiety which proved unsuccessful in this particular case, due to the hindered conformation of such epoxides as demonstrated by X-ray cristallographic analysis.</chunk>
</paragraph>
</abstract-subsection>
<abstract-subsection>
<title>
<chunk>Conclusion</chunk>
</title>
<paragraph>
<chunk>The biological activity of the synthesized glycomimetics has been evaluated towards 24 commercially available glycosidases. The weak observed activities can probably be related to the spatial disposition of the hydroxy and amino groups which depart too much from that realized in glycomimetics such as valiolamine, voglibose and valienamine. Nevertheless, the synthetic strategy described here is efficient and general, and could be extended to increase the diversity of the glycosidase inhibitors obtained since this diversity is introduced in an ultimate step of the synthesis.</chunk>
</paragraph>
</abstract-subsection>
</abstract-section>
<abstract-graphic public-id="1860-5397-1-12-graphical-abstract"/>
<album-graphic public-id="1860-5397-1-12-i4"/>
<album-graphic public-id="1860-5397-1-12-i5"/>
<album-graphic public-id="1860-5397-1-12-i6"/>
<external-link type="pmpid" public-id="16542023"/>
<external-link type="doi" public-id="10.1186/1860-5397-1-12"/>
<section>
<title>
<chunk>Introduction</chunk>
</title>
<paragraph>
<chunk>There is a considerable interest in the design of molecules able to mimic carbohydrates which play critical roles in various biological events such as for example, cell-cell recognition and adhesion, cell growth and differentiation.</chunk>
<link target="b1"/>
<link target="b2"/>
<link target="b3"/>
<link target="b4"/>
<link target="b5"/>
<link target="b6"/>
<link target="b7"/>
<link target="b8"/>
<link target="b9"/>
<chunk> In this context, the goal is to obtain new compounds with improved efficacy, stability and specificity. Thus, a change from an aldopyranoside to a 1-deoxy-iminosugar (</chunk>
<link target="f1"/>
<chunk>) decreases the vulnerability of the resulting glycomimetic towards glycosidases, while the core structure and essential network of hydroxyl functionalities for enzyme recognition are retained. An important example is the 1-deoxynojirimycin (DNJ) family, for which DNJ itself is a competitive inhibitor of &#945;-D-glucosidase (</chunk>
<chunk italic="yes">K</chunk>
<chunk subscript="yes">i</chunk>
<chunk> = 8&#8211;25 &#956;M),</chunk>
<link target="b10"/>
<chunk> while its derivatives miglustat (</chunk>
<chunk italic="yes">N-n</chunk>
<chunk>Bu DNJ, Zavesa</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>) and miglitol (</chunk>
<chunk italic="yes">N</chunk>
<chunk>-hydroxethyl DNJ, Glyset</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> or Diastabol</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>) have already found therapeutic applications in Gaucher's disease </chunk>
<link target="b11"/>
<chunk> and type 2 (non-insulino-dependant </chunk>
<chunk italic="yes">mellitus</chunk>
<chunk>) diabetes, </chunk>
<link target="b12"/>
<link target="b13"/>
<chunk> respectively. In the past decade, works have been targeted to carbasugars originally consisting of six-membered cyclitols, related to valiolamine, </chunk>
<link target="b14"/>
<chunk> voglibose, </chunk>
<link target="b15"/>
<chunk> valienamine, </chunk>
<link target="b16"/>
<chunk> and acarbose. </chunk>
<link target="b17"/>
<chunk> The last two compounds, marketed as Basen</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> and Glucor</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk> or Precose</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>, respectively, are also actually used in the treatment of type 2 diabetes. All these compounds can have their amino moiety protonated, and the corresponding ammonium ions mimick the charge of the presumed transition states or intermediates of the enzymatic glycoside hydrolyses </chunk>
<link target="b18"/>
<chunk>.</chunk>
</paragraph>
<figure id="f1">
<caption>
<paragraph>
<chunk>Sugars, iminosugars and carbasugars.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-1"/>
</figure>
<paragraph>
<chunk>More recently, attention has been increasingly accorded to seven- and eight-membered ring systems </chunk>
<link target="b19"/>
<link target="b20"/>
<link target="b21"/>
<link target="b22"/>
<link target="b23"/>
<link target="b24"/>
<link target="b25"/>
<link target="b26"/>
<link target="b27"/>
<link target="b28"/>
<link target="b29"/>
<link target="b30"/>
<chunk> in order to study the effect of the enhanced flexibility and of the new spatial distribution displayed by these structures on their adaptability in the active site of the enzyme.</chunk>
</paragraph>
<paragraph>
<chunk>As part of a program directed to the synthesis of potential glycosidases inhibitors, </chunk>
<link target="b31"/>
<link target="b32"/>
<chunk> we focused on the access to new eight-membered carbasugars (</chunk>
<link target="f2"/>
<chunk>, A = OH) and related aminocyclitols (A = NHR) from C</chunk>
<chunk subscript="yes">2</chunk>
<chunk>-symmetrical L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk>- or D-</chunk>
<chunk italic="yes">manno</chunk>
<chunk>- cyclooctene, easily available by ring closing metathesis of 1,9-diene derived from L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk>- or D-</chunk>
<chunk italic="yes">manno-</chunk>
<chunk>bis-epoxide </chunk>
<link target="b33"/>
<chunk>. Thus, synthetic potentialities of the newly created cyclic double bond were explored to reach hexa-substituted C8-glycomimetics.</chunk>
</paragraph>
<figure id="f2">
<caption>
<paragraph>
<chunk>Retrosynthetic analysis.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-2"/>
</figure>
</section>
<section>
<title>
<chunk>Results and discussion</chunk>
</title>
<paragraph>
<chunk>From the C</chunk>
<chunk subscript="yes">2</chunk>
<chunk>-symmetrical L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk>- or D-</chunk>
<chunk italic="yes">manno</chunk>
<chunk>- cyclooctene, </chunk>
<chunk bold="yes">1</chunk>
<chunk> or </chunk>
<chunk bold="yes">2</chunk>
<chunk>, to obtain the C8 hexa-substitued carbasugars a straightfoward approach seemed to be a dihydroxylation, whereas to obtain the corresponding aminocyclitols it could be an epoxidation followed by the nucleophilic opening of the epoxide moiety by a primary amine or another nitrogen nucleophile. Accordingly (</chunk>
<link target="s1"/>
<chunk>), treatment of the fully </chunk>
<chunk italic="yes">O</chunk>
<chunk>-protected L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk>-cyclooctene </chunk>
<chunk bold="yes">1</chunk>
<chunk> with a 5 mol% aqueous solution of osmium(IV) tetroxide </chunk>
<link target="b34"/>
<chunk> in acetone in the presence of </chunk>
<chunk italic="yes">N</chunk>
<chunk>-methylmorpholine oxide and </chunk>
<chunk italic="yes">tert</chunk>
<chunk>-butanol cleanly led to the expected </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-diol </chunk>
<chunk bold="yes">3</chunk>
<chunk> in 97% yield. In analogous manner, the D-</chunk>
<chunk italic="yes">manno</chunk>
<chunk>-cyclooctene </chunk>
<chunk bold="yes">2</chunk>
<chunk> gave the corresponding </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-diol </chunk>
<chunk bold="yes">4</chunk>
<chunk> in 97% yield. In each case, the </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-diol </chunk>
<chunk bold="yes">3</chunk>
<chunk> or </chunk>
<chunk bold="yes">4</chunk>
<chunk> has been isolated as a single stereoisomer because of the C</chunk>
<chunk subscript="yes">2</chunk>
<chunk>-axis of symmetry displayed by the L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk> or D-</chunk>
<chunk italic="yes">manno</chunk>
<chunk>-cyclooctenes </chunk>
<chunk bold="yes">1</chunk>
<chunk> and </chunk>
<chunk bold="yes">2</chunk>
<chunk>. Then, simultaneous acidic hydrolysis of all the </chunk>
<chunk italic="yes">O</chunk>
<chunk>-protective groups of </chunk>
<chunk bold="yes">3</chunk>
<chunk> and </chunk>
<chunk bold="yes">4</chunk>
<chunk> furnished the C8 hexa-substitued carbasugars </chunk>
<chunk bold="yes">5</chunk>
<chunk> and </chunk>
<chunk bold="yes">6</chunk>
<chunk> (80 to 97% overall yield for the two steps).</chunk>
</paragraph>
<scheme id="s1">
<caption>
<paragraph>
<chunk>Reagents and conditions: (a) OsO</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, NMO, </chunk>
<chunk italic="yes">t</chunk>
<chunk>BuOH, rt; (b) TFA, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, rt.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-i1"/>
</scheme>
<paragraph>
<chunk>Now, to reach the corresponding aminocyclitols, we turned to the epoxidation </chunk>
<link target="b35"/>
<chunk> of the cyclooctenes </chunk>
<chunk bold="yes">1</chunk>
<chunk> and </chunk>
<chunk bold="yes">2</chunk>
<chunk> (</chunk>
<link target="s2"/>
<chunk>). Thus, treatment of </chunk>
<chunk bold="yes">1</chunk>
<chunk> and </chunk>
<chunk bold="yes">2</chunk>
<chunk> with </chunk>
<chunk italic="yes">meta</chunk>
<chunk>-chloroperbenzoic acid in the presence of sodium hydrogen carbonate afforded the epoxides </chunk>
<chunk bold="yes">7</chunk>
<chunk> and </chunk>
<chunk bold="yes">8</chunk>
<chunk> in 91&#8211;96% yield. As precedently, because of the C</chunk>
<chunk subscript="yes">2</chunk>
<chunk>-axis of symmetry displayed by the L-</chunk>
<chunk italic="yes">ido</chunk>
<chunk> or D-</chunk>
<chunk italic="yes">manno</chunk>
<chunk>-cyclooctenes </chunk>
<chunk bold="yes">1</chunk>
<chunk> and </chunk>
<chunk bold="yes">2</chunk>
<chunk> the </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-epoxide </chunk>
<chunk bold="yes">7</chunk>
<chunk> or </chunk>
<chunk bold="yes">8</chunk>
<chunk> has been isolated as a single stereoisomer. However, all attempts to open the epoxide ring involving various nucleophiles, sodium azide, benzylamine, </chunk>
<chunk italic="yes">n</chunk>
<chunk>-butylamine, or serinol in different experimental conditions, protic or aprotic solvent, presence or absence of a Lewis acid catalyst such as ytterbium triflate, revealed unsuccessful, only leading to recover the starting material.</chunk>
</paragraph>
<scheme id="s2">
<caption>
<paragraph>
<chunk>Reagents and conditions: (a) </chunk>
<chunk italic="yes">m</chunk>
<chunk>CPBA, CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>Cl</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, NaHCO</chunk>
<chunk subscript="yes">3</chunk>
<chunk>, rt; (b) see text.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-i2"/>
</scheme>
<paragraph>
<chunk>To overcome this difficulty, we turned to a more electrophilic sulfate moiety </chunk>
<link target="b36"/>
<chunk> (</chunk>
<link target="s3"/>
<chunk>). Thus, treatment of the </chunk>
<chunk italic="yes">cis</chunk>
<chunk>-diols </chunk>
<chunk bold="yes">3</chunk>
<chunk> and </chunk>
<chunk bold="yes">4</chunk>
<chunk> with thionyl chloride in the presence of triethylamine followed by subsequent oxidation with sodium periodate in the presence of ruthenium trichloride gave the cyclic sulfates </chunk>
<chunk bold="yes">9</chunk>
<chunk> and </chunk>
<chunk bold="yes">10</chunk>
<chunk> in 80&#8211;100% yield. Nucleophilic opening of these sulfates by sodium azide in DMF at 80&#176;C, </chunk>
<link target="b37"/>
<chunk> followed by acidic hydrolysis of the resulting acyclic sulfate ester cleanly afforded the corresponding azido-alcohols </chunk>
<chunk bold="yes">11</chunk>
<chunk> and </chunk>
<chunk bold="yes">12</chunk>
<chunk>, isolated as single stereoisomers in excellent yield (95&#8211;98%). No other isomer of </chunk>
<chunk bold="yes">11</chunk>
<chunk> or </chunk>
<chunk bold="yes">12</chunk>
<chunk> was detected by NMR analysis, indicating that the ring-opening reaction is highly regioselective and results in the </chunk>
<chunk italic="yes">anti</chunk>
<chunk> addition of the azido group on the opposite side of the bulky TBDMS group in &#946;-position. However, it has to be pointed out that more hindered nucleophiles, such as primary amines, revealed unable to open the cyclic sulfate </chunk>
<chunk bold="yes">9</chunk>
<chunk> or </chunk>
<chunk bold="yes">10</chunk>
<chunk>.</chunk>
</paragraph>
<scheme id="s3">
<caption>
<paragraph>
<chunk>Reagents and conditions: (a) </chunk>
<chunk italic="yes">i</chunk>
<chunk> : SOCl</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, Et</chunk>
<chunk subscript="yes">3</chunk>
<chunk>N, CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>Cl</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, 0&#176;C; </chunk>
<chunk italic="yes">ii</chunk>
<chunk> : RuCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk>, NaIO</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, CCl</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>CN, 0&#176;C to rt; (b) NaN</chunk>
<chunk subscript="yes">3</chunk>
<chunk>, DMF, 80&#176;C; (c) H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, Pd black, EtOAc; (d) </chunk>
<chunk italic="yes">i:</chunk>
<chunk> TFA, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, rt; </chunk>
<chunk italic="yes">ii:</chunk>
<chunk> Dowex-50WX8 H</chunk>
<chunk superscript="yes">+</chunk>
<chunk> resin, 1% NH</chunk>
<chunk subscript="yes">4</chunk>
<chunk>OH; (e) Ti(O</chunk>
<chunk italic="yes">i</chunk>
<chunk>Pr)</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, OC(CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O)</chunk>
<chunk subscript="yes">2</chunk>
<chunk>CMe</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>Cl</chunk>
<chunk subscript="yes">2</chunk>
<chunk> then NaBH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>CN, EtOH.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-i3"/>
</scheme>
<paragraph>
<chunk>The absolute configurations of </chunk>
<chunk bold="yes">11</chunk>
<chunk> and </chunk>
<chunk bold="yes">12</chunk>
<chunk> were established by NMR studies. </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H signals were assigned (</chunk>
<link target="t1"/>
<chunk>) using 2D-COSY and 2D-TOCSY experiments starting from hydroxyl group at C8-position.</chunk>
</paragraph>
<table id="t1">
<caption>
<paragraph>
<chunk>Selected </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H NMR data for compound </chunk>
<chunk bold="yes">11</chunk>
<chunk> in CDCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk> at 500 MHz.</chunk>
</paragraph>
</caption>
<table-row type="header1">
<table-cell>
<paragraph>
<chunk>Proton</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>&#948;</chunk>
<chunk superscript="yes">1</chunk>
<chunk>H (ppm)</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">2</chunk>
<chunk italic="yes">J</chunk>
<chunk>,</chunk>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk> (Hz)</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell column-span="3" type="horizontal-line"/>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>1</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>3.73</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1-2a</chunk>
<chunk> = 2.2</chunk>
</paragraph>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1-2b</chunk>
<chunk> = 9.0</chunk>
</paragraph>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1-8</chunk>
<chunk> = 9.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>2a (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S)</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>2.06</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">2</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">2a-2b</chunk>
<chunk> = -15.4</chunk>
</paragraph>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">2a-3</chunk>
<chunk> = 6.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>2b (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>R)</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>1.90</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">2b-3</chunk>
<chunk> = 1.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>3</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>4.04</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">3-4</chunk>
<chunk> = 4.2</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>4</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>3.50</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">4-5</chunk>
<chunk> = 9.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>5</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>3.59</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">5-6</chunk>
<chunk> = 6.3</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>6</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>3.94</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">6-7a</chunk>
<chunk> = 1.8</chunk>
</paragraph>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">6-7b</chunk>
<chunk> = 5.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>7a (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>R)</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>2.06</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">2</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">7a-7b</chunk>
<chunk> = -15.4</chunk>
</paragraph>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">7a-8</chunk>
<chunk> = 8.8</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>7b (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S)</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>1.95</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">7b-8</chunk>
<chunk> = 1.5</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>8</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>3.73</chunk>
</paragraph>
</table-cell>
<table-cell/>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>8-OH</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>2.39</chunk>
</paragraph>
</table-cell>
<table-cell/>
</table-row>
</table>
<paragraph>
<chunk>The determination of all the coupling constants and particularly of the </chunk>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1,8</chunk>
<chunk> was not possible by homodecoupling experiments. Thus, numerical simulation was used for an in depth study of the complex coupling patterns to set the parameters in complete analogy with regard to the experimental spectra. These </chunk>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1H,1H</chunk>
<chunk> coupling constants, determined by simulation (</chunk>
<link target="f3"/>
<chunk>) of 1D spectra with NMR-SIM started from XWIN-NMR software (Bruker), are gathered in </chunk>
<link target="t1"/>
<chunk>. These values allowed us to restrain the number of conformations for the eight-membered ring. For example, in compound </chunk>
<chunk bold="yes">11</chunk>
<chunk>, the large </chunk>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1H,1H</chunk>
<chunk> coupling constants found between H1 and H8, H1 and H2 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>R), H8 and H7 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>R), H4 and H5, are in agreement with protons in a pseudo-axial position. On the other hand, the small </chunk>
<chunk superscript="yes">3</chunk>
<chunk italic="yes">J</chunk>
<chunk subscript="yes">1H,1H</chunk>
<chunk> coupling constants found between H1 and H2 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S), H8 and H7 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S) indicate a pseudo-equatorial position of protons H2 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S) and H7 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S). NOE measurements and finally Molecular Dynamic calculations using Insight II software (Biosym Technologies, San Diego, CA) allowed to deduce the structure of </chunk>
<chunk bold="yes">11</chunk>
<chunk> (</chunk>
<link target="f4"/>
<chunk>). Prochiral H2 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S) and H7 (</chunk>
<chunk italic="yes">pro</chunk>
<chunk>S) protons displayed strong NOEs with the TBDMS groups, respectively in positions 3 and 6, indicating they are pointing away from the C8 ring in a pseudo-equatorial position. Hence, the protons H7 (proR), H6, H4 are close together and represent one face (upper) of the C8 ring, while H2 (proR), H5, H3 represent the other face. Then, in compound </chunk>
<chunk bold="yes">11,</chunk>
<chunk> the strong NOEs H1-H4 and H8-H5 indicate that H1 and H8 are in opposite side in an </chunk>
<chunk italic="yes">anti</chunk>
<chunk> configuration with pseudo-axial positions. A similar approach was applied for the structural determination of </chunk>
<chunk bold="yes">12</chunk>
<chunk>.</chunk>
</paragraph>
<figure id="f3">
<caption>
<paragraph>
<chunk>1D proton NMR spectra of the C8 ring in compound </chunk>
<chunk bold="yes">11</chunk>
<chunk> (upper) and the simulated signals (down) on the basis of the chemical shifts and coupling constants summarized in Table 1.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-3"/>
</figure>
<figure id="f4">
<caption>
<paragraph>
<chunk>Schematic representation of the NOEs (indicated with arrows) found to deduce the structure of </chunk>
<chunk bold="yes">11</chunk>
<chunk>. Bold arrows show the NOEs found between the protons (in bold) of the upper face of the C8 ring. Prochiral </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H are labelled </chunk>
<chunk italic="yes">p</chunk>
<chunk>R or </chunk>
<chunk italic="yes">p</chunk>
<chunk>S.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-4"/>
</figure>
<paragraph>
<chunk>The low reactivity of the epoxide function of </chunk>
<chunk bold="yes">7</chunk>
<chunk> could be explained by the steric hindrance of the </chunk>
<chunk italic="yes">tert</chunk>
<chunk>-butyldimethylsilyloxy groups in &#946;-positions as confirmed by the X-ray crystallography (</chunk>
<link target="f5"/>
<chunk>). Furthermore, it seems that the C8-carbacycle of the tricyclic system [5-8-3] adopts a twist-boat-chair conformation. Whereas that of the sulfate </chunk>
<chunk bold="yes">9</chunk>
<chunk>, which crystallizes as a dimer, constituted by a tricyclic system [5-8-5] adopts a more flexible boat-chair conformation, thus allowing its opening by a linear nucleophile (azide anion), but not by a more hindered nucleophile (primary amine).</chunk>
</paragraph>
<figure id="f5">
<caption>
<paragraph>
<chunk>X-ray structure of epoxide </chunk>
<chunk bold="yes">7</chunk>
<chunk> (upper) and sulfate </chunk>
<chunk bold="yes">9</chunk>
<chunk> (down) solved using SHELXS and anisotropically refined using SHELXL programs [38].</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-1-12-5"/>
</figure>
<paragraph>
<chunk>With the key enantiomerically pure azido-alcohol </chunk>
<chunk bold="yes">11</chunk>
<chunk> and </chunk>
<chunk bold="yes">12</chunk>
<chunk> in hands, we next turned to the obtention of C8-aminocyclitols. Thus, reduction of the azido group of </chunk>
<chunk bold="yes">11</chunk>
<chunk> by dihydrogen in the presence of palladium black in ethyl acetate (</chunk>
<link target="s3"/>
<chunk>) afforded the amino-alcohol </chunk>
<chunk bold="yes">13</chunk>
<chunk> which could be submitted to acidic hydrolysis of the </chunk>
<chunk italic="yes">O</chunk>
<chunk>-protective groups to give, after purification by ion-exchange chromatography, the targeted aminocyclitol </chunk>
<chunk bold="yes">15</chunk>
<chunk> </chunk>
<link target="b20"/>
<chunk> (95% overall yield from </chunk>
<chunk bold="yes">11</chunk>
<chunk>). Alternatively, to obtain an analog of voglibose, the amine function of </chunk>
<chunk bold="yes">13</chunk>
<chunk> could be alkylated </chunk>
<chunk italic="yes">via</chunk>
<chunk> a reductive amination </chunk>
<link target="b38"/>
<chunk> with a dihydroxyacetone derivative. Thus, treatment of the amine </chunk>
<chunk bold="yes">13</chunk>
<chunk> by the commercially available 2,2-dimethyl-1,3-dioxan-5-one in the presence of titanium(IV) tetra-isopropoxide followed by the cyanoborohydride reduction of the imine intermediate gave the expected </chunk>
<chunk italic="yes">N</chunk>
<chunk>-alkylated aminocyclitol </chunk>
<chunk bold="yes">17</chunk>
<chunk> (46% overall yield from </chunk>
<chunk bold="yes">11</chunk>
<chunk>). Then, simultaneous acidic hydrolysis of all protective groups led to the C8-voglibose mimetic </chunk>
<chunk bold="yes">19</chunk>
<chunk> after purification by ion-exchange chromatography. The same sequence of reactions was uneventfully applied to the azido-alcohol </chunk>
<chunk bold="yes">12</chunk>
<chunk> to afford the aminocyclitols </chunk>
<chunk bold="yes">16</chunk>
<chunk> and </chunk>
<chunk bold="yes">20</chunk>
<chunk>.</chunk>
</paragraph>
<paragraph>
<chunk>The new C8-carbasugars </chunk>
<chunk bold="yes">5</chunk>
<chunk> and </chunk>
<chunk bold="yes">6</chunk>
<chunk> and C8-aminocyclitols </chunk>
<chunk bold="yes">15</chunk>
<chunk>, </chunk>
<chunk bold="yes">16</chunk>
<chunk>, </chunk>
<chunk bold="yes">19</chunk>
<chunk> and </chunk>
<chunk bold="yes">20</chunk>
<chunk> have been assayed for their inhibitory activity towards 24 commercially available glycosidases </chunk>
<link target="b39"/>
<link target="b40"/>
<chunk>. They did not inhibit the following enzymes at 1 mM concentration and optimal pH : &#945;-D-glucosidases (maltase) from yeast and rice, &#946;-D-glucosidase from </chunk>
<chunk italic="yes">caldocellum saccharolyticum</chunk>
<chunk>, &#945;-L-fucosidases from bovine epididymis and human placenta, &#945;-D-galactosidases from coffee beans and </chunk>
<chunk italic="yes">Escherichia coli</chunk>
<chunk>, &#946;-D-galactosidases from </chunk>
<chunk italic="yes">Escherichia coli</chunk>
<chunk>, bovine liver, </chunk>
<chunk italic="yes">Aspergillus niger</chunk>
<chunk> and </chunk>
<chunk italic="yes">Aspergillus orizae</chunk>
<chunk>, &#945;-</chunk>
<chunk italic="yes">N</chunk>
<chunk>-acetylgalactosaminidase from chicken liver, &#946;-</chunk>
<chunk italic="yes">N</chunk>
<chunk>-acetylglucosaminidases from Jack bean, bovine epididymis A and bovine epididymis B, &#945;-D-mannosidase from almonds, &#946;-D-mannosidase from </chunk>
<chunk italic="yes">Helix pomatia</chunk>
<chunk>, and &#946;-xylosidase from </chunk>
<chunk italic="yes">Aspergillus niger</chunk>
<chunk>. For other enzymes: &#945;-D-glucosidase from </chunk>
<chunk italic="yes">Bacillus stearothermophilus</chunk>
<chunk>, amyloglucosidase from </chunk>
<chunk italic="yes">Aspergillus niger</chunk>
<chunk> and </chunk>
<chunk italic="yes">Rhizopus</chunk>
<chunk> mold, &#946;-D-glucosidase from almonds, &#945;-L-fucosidase from bovine kidney, and &#945;-D-mannosidase from Jack beans the results are shown in </chunk>
<link target="t2"/>
<chunk>. Each of these new compounds revealed weak inhibitor of the tested enzymes with a percentage of inhibition not over than 30%. These results show that the enhanced flexibility displayed by C8-glycomimetics does not seem to be correlated with an increase in observed activity. Thus, for example we had previously shown that the corresponding C7-voglibose mimic exhibited interesting activity towards amyloglucosidases from </chunk>
<chunk italic="yes">Aspergillus niger</chunk>
<chunk> and </chunk>
<chunk italic="yes">Rhizopus</chunk>
<chunk> mold (35 and 18 &#956;M respectively, unpublished results). Furthermore, even if data concerning biological activity of C8-glycomimetics are seldom, the reported activities are often weak </chunk>
<link target="b24"/>
<link target="b25"/>
<link target="b26"/>
<link target="b27"/>
<link target="b28"/>
<link target="b29"/>
<link target="b30"/>
<chunk>.</chunk>
</paragraph>
<table id="t2">
<caption>
<paragraph>
<chunk>Inhibitory activities for C8-carbasugars </chunk>
<chunk bold="yes">5&#8211;6</chunk>
<chunk>, and for C8-aminocyclitols </chunk>
<chunk bold="yes">15</chunk>
<chunk>, </chunk>
<chunk bold="yes">16</chunk>
<chunk>, </chunk>
<chunk bold="yes">19</chunk>
<chunk> and </chunk>
<chunk bold="yes">20</chunk>
<chunk>. Percentage of inhibitions at 1 mM.</chunk>
</paragraph>
</caption>
<table-row type="header1">
<table-cell>
<paragraph>
<chunk>Enzyme</chunk>
<chunk superscript="yes">a</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">5</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">6</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">15</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">16</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">19</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk bold="yes">20</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell column-span="7" type="horizontal-line"/>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>&#945;-D-Glucosidase</chunk>
</paragraph>
</table-cell>
<table-cell/>
<table-cell/>
<table-cell/>
<table-cell/>
<table-cell/>
<table-cell/>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>- </chunk>
<chunk italic="yes">Aspergillus niger</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>28%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>27%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>29%</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>- </chunk>
<chunk italic="yes">Rhizopus</chunk>
<chunk> mold</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>20%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>21%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>23%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>20%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>28%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>27%</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>- </chunk>
<chunk italic="yes">Bac. stearotherm.</chunk>
<chunk italic="yes" superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>9%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>5%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>6%</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>&#946;-D-Glucosidase</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>7%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>11%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>6%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>19%</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>&#945;-D-Mannosidase</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>5%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>16%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>8%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>10%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>8%</chunk>
</paragraph>
</table-cell>
</table-row>
<table-row>
<table-cell>
<paragraph>
<chunk>&#945;-L-Fucosidase</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>14%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>13%</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
<table-cell>
<paragraph>
<chunk>n.i.</chunk>
<chunk superscript="yes">b</chunk>
</paragraph>
</table-cell>
</table-row>
<table-footer>
<paragraph>
<chunk superscript="yes">a</chunk>
<chunk>See text; </chunk>
<chunk superscript="yes">b</chunk>
<chunk>No inhibition detected.</chunk>
</paragraph>
</table-footer>
</table>
<paragraph>
<chunk>In summary, utilizing the readily available polyhydroxylated L-ido or D-manno-cyclooctenes, coming from ring closing metathesis of C2-symmetrical 1,9-dienes, we have accomplished the synthesis of a range of new hexa-substituted C8-glycomimetics in enantiopure form. Transformation of the cyclic double bond involved </chunk>
<chunk italic="yes">syn</chunk>
<chunk>-dihydroxylation, then introduction of an azido group by opening of a cyclic sulfate followed by reduction and eventual alkylation of the resulting amine.</chunk>
</paragraph>
<paragraph>
<chunk>According to this strategy and to the nature of the ketones involved in the final reductive amination, various aminocyclitols could be synthesized. Thus, in this study two carbasugars and four aminocyclitols were obtained. Biological evaluation of these compounds towards 24 commercially available glycosidases have been carried out. For these C8-glycomimetics, weak activities were observed, which can probably be explained by a too high conformational flexibility of such structures.</chunk>
</paragraph>
</section>
<section>
<title>
<chunk>Experimental</chunk>
</title>
<paragraph>
<chunk>See </chunk>
<link target="si1"/>
<chunk>.</chunk>
</paragraph>
</section>
<supporting-information>
<supporting-information-file id="si1" public-id="1860-5397-1-12-S1">
<caption>
<paragraph>
<chunk>Additional information.</chunk>
</paragraph>
</caption>
</supporting-information-file>
</supporting-information>
<acknowledgements>
<paragraph>
<chunk>We gratefully acknowledge Pr P. Vogel and Ms C. Schuetz, Ecole Polytechnique F&#233;d&#233;rale de Lausanne, Switzerland, for their expertise in biological tests.</chunk>
</paragraph>
</acknowledgements>
<reference id="b1" type="article" volume="3" first-page="633" last-page="649">
<reference-author first-name="N" middle-names="B" last-name="Drinnan"/>
<reference-author first-name="F" last-name="Vari"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487737"/>
<external-link type="pmpid" public-id="14529505"/>
</reference>
<reference id="b2" type="article" volume="3" first-page="651" last-page="658">
<reference-author first-name="F" last-name="Peri"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487700"/>
<external-link type="pmpid" public-id="14529506"/>
</reference>
<reference id="b3" type="article" volume="3" first-page="659" last-page="667">
<reference-author first-name="P" last-name="Fugedi"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487755"/>
<external-link type="pmpid" public-id="14529507"/>
</reference>
<reference id="b4" type="article" volume="3" first-page="669" last-page="678">
<reference-author first-name="T" middle-names="A" last-name="Houston"/>
<reference-author first-name="J" middle-names="T" last-name="Blanchfield"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487827"/>
<external-link type="pmpid" public-id="14529508"/>
</reference>
<reference id="b5" type="article" volume="3" first-page="679" last-page="687">
<reference-author first-name="S" middle-names="R" last-name="Chhabra"/>
<reference-author first-name="A" middle-names="S" last-name="Rahim"/>
<reference-author first-name="B" last-name="Kellam"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487791"/>
<external-link type="pmpid" public-id="14529509"/>
</reference>
<reference id="b6" type="article" volume="3" first-page="689" last-page="702">
<reference-author first-name="T" middle-names="L" last-name="Lowary"/>
<source>
<chunk>Mini-Rev. Med. Chem.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.2174/1389557033487683"/>
<external-link type="pmpid" public-id="14529510"/>
</reference>
<reference id="b7" type="article" volume="291" first-page="2337" last-page="2378">
<reference-author first-name="S" last-name="Hurtley"/>
<reference-author first-name="R" last-name="Service"/>
<reference-author first-name="P" last-name="Szuromi"/>
<source>
<chunk>Science</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1126/science.291.5512.2337"/>
</reference>
<reference id="b8" type="article" volume="38" first-page="2300" last-page="2324">
<reference-author first-name="P" last-name="Sears"/>
<reference-author first-name="C" middle-names="H" last-name="Wong"/>
<source>
<chunk>Angew. Chem., Int. Ed.</chunk>
</source>
<publication-date year="1999"/>
<external-link type="doi" public-id="10.1002/(SICI)1521-3773(19990816)38:16&lt;2300::AID-ANIE2300&gt;3.3.CO;2-Y"/>
</reference>
<reference id="b9" type="book" publisher-name="Wiley-VCH" publisher-location="Weinheim">
<reference-author first-name="Y" last-name="Chapleur"/>
<source>
<chunk>Carbohydrate Mimics: Concepts and Methods</chunk>
</source>
<publication-date year="1997"/>
</reference>
<reference id="b10" type="article" volume="2" first-page="199" last-page="210">
<reference-author first-name="B" last-name="Winchester"/>
<reference-author first-name="G" middle-names="W J" last-name="Fleet"/>
<source>
<chunk>Glycobiology</chunk>
</source>
<publication-date year="1992"/>
<external-link type="doi" public-id="10.1093/glycob/2.3.199"/>
<external-link type="pmpid" public-id="1498417"/>
</reference>
<reference id="b11" type="article" volume="276" first-page="428" last-page="431">
<reference-author first-name="F" middle-names="M" last-name="Platt"/>
<reference-author first-name="G" middle-names="R" last-name="Niese"/>
<reference-author first-name="G" last-name="Reinkensmeir"/>
<reference-author first-name="M" middle-names="J" last-name="Townsend"/>
<reference-author first-name="V" middle-names="H" last-name="Perry"/>
<reference-author first-name="R" middle-names="L" last-name="Proia"/>
<reference-author first-name="B" last-name="Winchester"/>
<reference-author first-name="R" middle-names="A" last-name="Dwek"/>
<reference-author first-name="T" middle-names="D" last-name="Buters"/>
<source>
<chunk>Science</chunk>
</source>
<publication-date year="1997"/>
<external-link type="doi" public-id="10.1126/science.276.5311.428"/>
<external-link type="pmpid" public-id="9103204"/>
</reference>
<reference id="b12" type="article" volume="57" first-page="19" last-page="29">
<reference-author first-name="A" middle-names="D" last-name="Mooradian"/>
<reference-author first-name="J" middle-names="E" last-name="Thuman"/>
<source>
<chunk>Drugs</chunk>
</source>
<publication-date year="1999"/>
<external-link type="doi" public-id="10.2165/00003495-199957010-00003"/>
<external-link type="pmpid" public-id="9951949"/>
</reference>
<reference id="b13" type="article" volume="59" first-page="521" last-page="549">
<reference-author first-name="L" middle-names="J" last-name="Scott"/>
<reference-author first-name="C" middle-names="M" last-name="Spencer"/>
<source>
<chunk>Drugs</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.2165/00003495-200059030-00012"/>
<external-link type="pmpid" public-id="10776834"/>
</reference>
<reference id="b14" type="article" volume="37" first-page="1301" last-page="1307">
<reference-author first-name="Y" last-name="Kameda"/>
<reference-author first-name="N" last-name="Asano"/>
<reference-author first-name="M" last-name="Yoshikawa"/>
<reference-author first-name="M" last-name="Takeuchi"/>
<reference-author first-name="T" last-name="Yamaguchi"/>
<reference-author first-name="K" last-name="Matsui"/>
<reference-author first-name="S" last-name="Horii"/>
<reference-author first-name="H" last-name="Fukase"/>
<source>
<chunk>J. Antibiot.</chunk>
</source>
<publication-date year="1984"/>
<external-link type="pmpid" public-id="6392268"/>
</reference>
<reference id="b15" type="article" volume="29" first-page="1038" last-page="1046">
<reference-author first-name="S" last-name="Horii"/>
<reference-author first-name="H" last-name="Fukase"/>
<reference-author first-name="T" last-name="Matsuo"/>
<reference-author first-name="Y" last-name="Kameda"/>
<reference-author first-name="N" last-name="Asano"/>
<reference-author first-name="K" last-name="Matsui"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="1986"/>
<external-link type="doi" public-id="10.1021/jm00156a023"/>
<external-link type="pmpid" public-id="3519969"/>
</reference>
<reference id="b16" type="article" volume="103" first-page="1955" last-page="1977">
<reference-author first-name="X" last-name="Chen"/>
<reference-author first-name="Y" last-name="Fan"/>
<reference-author first-name="Y" last-name="Zheng"/>
<reference-author first-name="Y" last-name="Chen"/>
<source>
<chunk>Chem. Rev.</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1021/cr0102260"/>
<external-link type="pmpid" public-id="12744697"/>
</reference>
<reference id="b17" type="article" volume="20" first-page="744" last-page="761">
<reference-author first-name="E" last-name="Truscheit"/>
<reference-author first-name="W" last-name="Frommer"/>
<reference-author first-name="B" last-name="Junge"/>
<reference-author first-name="L" last-name="M&#252;ller"/>
<reference-author first-name="D" middle-names="D" last-name="Schmidt"/>
<reference-author first-name="W" last-name="Wingender"/>
<source>
<chunk>Angew. Chem., Int. Ed. Engl.</chunk>
</source>
<publication-date year="1981"/>
<external-link type="doi" public-id="10.1002/anie.198107441"/>
</reference>
<reference id="b18" type="article" volume="102" first-page="515" last-page="533">
<reference-author first-name="V" middle-names="H" last-name="Lillelund"/>
<reference-author first-name="H" middle-names="H" last-name="Jensen"/>
<reference-author first-name="X" last-name="Liang"/>
<reference-author first-name="M" last-name="Bols"/>
<source>
<chunk>Chem. Rev.</chunk>
</source>
<publication-date year="2002"/>
<external-link type="doi" public-id="10.1021/cr000433k"/>
<external-link type="pmpid" public-id="11841253"/>
</reference>
<reference id="b19" type="article" volume="59" first-page="8705" last-page="8720">
<reference-author first-name="C" last-name="Gravier-Pelletier"/>
<reference-author first-name="W" last-name="Maton"/>
<reference-author first-name="T" last-name="Dintinger"/>
<reference-author first-name="C" last-name="Tellier"/>
<reference-author first-name="Y" last-name="Le Merrer"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1016/j.tet.2003.09.049"/>
</reference>
<reference id="b20" type="article" volume="67" first-page="3705" last-page="3717">
<reference-author first-name="J" last-name="Marco-Contelles"/>
<reference-author first-name="E" last-name="de Opazo"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="2002"/>
<external-link type="doi" public-id="10.1021/jo0111107"/>
<external-link type="pmpid" public-id="12027684"/>
</reference>
<reference id="b21" type="article" volume="65" first-page="5416" last-page="5419">
<reference-author first-name="J" last-name="Marco-Contelles"/>
<reference-author first-name="E" last-name="de Opazo"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="2002"/>
<external-link type="doi" public-id="10.1021/jo000110o"/>
</reference>
<reference id="b22" type="article" volume="40" first-page="4445" last-page="4448">
<reference-author first-name="J" last-name="Marco-Contelles"/>
<reference-author first-name="E" last-name="de Opazo"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="1999"/>
<external-link type="doi" public-id="10.1016/S0040-4039(99)00769-8"/>
</reference>
<reference id="b23" type="article" volume="31" first-page="333" last-page="341">
<reference-author first-name="C" middle-names="R" last-name="Johnson"/>
<source>
<chunk>Acc. Chem. Res.</chunk>
</source>
<publication-date year="1998"/>
<external-link type="doi" public-id="10.1021/ar970013q"/>
</reference>
<reference id="b24" type="article" first-page="2828" last-page="2829">
<reference-author first-name="G" last-name="Mehta"/>
<reference-author first-name="K" last-name="Pallavi"/>
<source>
<chunk>Chem. Commun.</chunk>
</source>
<publication-date year="2002"/>
<external-link type="doi" public-id="10.1039/b208918a"/>
</reference>
<reference id="b25" type="article" first-page="1053" last-page="1059">
<reference-author first-name="W" last-name="Wang"/>
<reference-author first-name="Y" last-name="Zhang"/>
<reference-author first-name="H" last-name="Zhou"/>
<reference-author first-name="Y" last-name="Bl&#233;riot"/>
<reference-author first-name="P" last-name="Sina&#255;"/>
<source>
<chunk>Eur. J. Org. Chem.</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1002/1099-0690(200103)2001:6&lt;1053::AID-EJOC1053&gt;3.3.CO;2-J"/>
</reference>
<reference id="b26" type="article" volume="42" first-page="1769" last-page="1772">
<reference-author first-name="P" middle-names="A V" last-name="van Hooft"/>
<reference-author first-name="G" middle-names="A" last-name="van der Marel"/>
<reference-author first-name="C" middle-names="A A" last-name="van Boeckel"/>
<reference-author first-name="J" middle-names="H" last-name="van Boom"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1016/S0040-4039(00)02318-2"/>
</reference>
<reference id="b27" type="article" volume="66" first-page="4094" last-page="4096">
<reference-author first-name="F" middle-names="D" last-name="Boyer"/>
<reference-author first-name="I" last-name="Hanna"/>
<reference-author first-name="S" middle-names="P" last-name="Nolan"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="2001"/>
<external-link type="doi" public-id="10.1021/jo0155761"/>
<external-link type="pmpid" public-id="11375046"/>
</reference>
<reference id="b28" type="article" volume="41" first-page="5341" last-page="5345">
<reference-author first-name="J" last-name="Marco-Contelles"/>
<reference-author first-name="E" last-name="de Opazo"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0040-4039(00)00837-6"/>
</reference>
<reference id="b29" type="article" volume="39" first-page="2466" last-page="2467">
<reference-author first-name="W" last-name="Wang"/>
<reference-author first-name="Y" last-name="Zhang"/>
<reference-author first-name="M" last-name="Sollogoub"/>
<reference-author first-name="P" last-name="Sina&#255;"/>
<source>
<chunk>Angew. Chem., Int. Ed.</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1002/1521-3773(20000717)39:14&lt;2466::AID-ANIE2466&gt;3.0.CO;2-U"/>
</reference>
<reference id="b30" type="article" volume="41" first-page="5483" last-page="5487">
<reference-author first-name="J" last-name="Armbruster"/>
<reference-author first-name="F" last-name="Stelzer"/>
<reference-author first-name="P" last-name="Landenberger"/>
<reference-author first-name="C" last-name="Wieber"/>
<reference-author first-name="D" last-name="Hunkler"/>
<reference-author first-name="M" last-name="Keller"/>
<reference-author first-name="H" last-name="Prinzbach"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0040-4039(00)00905-9"/>
</reference>
<reference id="b31" type="article" volume="61" first-page="7094" last-page="7104">
<reference-author first-name="O" last-name="Andriuzzi"/>
<reference-author first-name="C" last-name="Gravier-Pelletier"/>
<reference-author first-name="P" last-name="Vogel"/>
<reference-author first-name="Y" last-name="Le Merrer"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="2005"/>
<external-link type="doi" public-id="10.1016/j.tet.2005.05.066"/>
</reference>
<reference id="b32" type="article" volume="59" first-page="2693" last-page="2700">
<reference-author first-name="I" last-name="McCort"/>
<reference-author first-name="M" last-name="Sani&#232;re"/>
<reference-author first-name="Y" last-name="Le Merrer"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="2003"/>
<external-link type="doi" public-id="10.1016/S0040-4020(03)00257-6"/>
</reference>
<reference id="b33" type="article" volume="45" first-page="8043" last-page="8046">
<reference-author first-name="O" last-name="Andriuzzi"/>
<reference-author first-name="C" last-name="Gravier-Pelletier"/>
<reference-author first-name="Y" last-name="Le Merrer"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="2004"/>
<external-link type="doi" public-id="10.1016/j.tetlet.2004.08.172"/>
</reference>
<reference id="b34" type="article" volume="56" first-page="9781" last-page="9790">
<reference-author first-name="J" middle-names="M" last-name="Dougherty"/>
<reference-author first-name="D" middle-names="A" last-name="Probst"/>
<reference-author first-name="R" middle-names="E" last-name="Robinson"/>
<reference-author first-name="J" middle-names="D" last-name="Moore"/>
<reference-author first-name="T" middle-names="A" last-name="Klein"/>
<reference-author first-name="K" middle-names="A" last-name="Snelgrove"/>
<reference-author first-name="P" middle-names="R" last-name="Hanson"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0040-4020(00)00885-1"/>
</reference>
<reference id="b35" type="article" volume="56" first-page="9633" last-page="9640">
<reference-author first-name="S" last-name="Barett"/>
<reference-author first-name="P" last-name="O'Brien"/>
<reference-author first-name="H" middle-names="C" last-name="Steffens"/>
<reference-author first-name="T" middle-names="D" last-name="Towers"/>
<reference-author first-name="M" last-name="Voith"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="2000"/>
<external-link type="doi" public-id="10.1016/S0040-4020(00)00911-X"/>
</reference>
<reference id="b36" type="article" volume="110" first-page="7538">
<reference-author first-name="Y" last-name="Gao"/>
<reference-author first-name="K" middle-names="B" last-name="Sharpless"/>
<source>
<chunk>J. Am. Chem. Soc.</chunk>
</source>
<publication-date year="1988"/>
<external-link type="doi" public-id="10.1021/ja00230a045"/>
</reference>
<reference id="b37" type="article" volume="30" first-page="655" last-page="659">
<reference-author first-name="B" last-name="Moon Kim"/>
<reference-author first-name="K" middle-names="B" last-name="Sharpless"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="1989"/>
<external-link type="doi" public-id="10.1016/S0040-4039(01)80274-4"/>
</reference>
<reference id="b41" type="software" publisher-name="University of G&#246;ttingen" publisher-location="Germany">
<reference-author first-name="G" middle-names="M" last-name="Sheldrick"/>
<source>
<chunk>SHELXL97. Program for the refinement of crystal structures</chunk>
</source>
<publication-date year="1997"/>
</reference>
<reference id="b38" type="article" volume="55" first-page="2552" last-page="2554">
<reference-author first-name="R" middle-names="J" last-name="Mattson"/>
<reference-author first-name="K" middle-names="M" last-name="Pham"/>
<reference-author first-name="D" middle-names="J" last-name="Leuck"/>
<reference-author first-name="K" middle-names="A" last-name="Cowen"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="1990"/>
<external-link type="doi" public-id="10.1021/jo00295a060"/>
</reference>
<reference id="b39" type="article" volume="221" first-page="593" last-page="597">
<reference-author first-name="R" last-name="Saul"/>
<reference-author first-name="J" middle-names="P" last-name="Chambers"/>
<reference-author first-name="R" middle-names="J" last-name="Molyneux"/>
<reference-author first-name="A" middle-names="D" last-name="Elbein"/>
<source>
<chunk>Arch. Biochem. Biophys.</chunk>
</source>
<publication-date year="1983"/>
<external-link type="doi" public-id="10.1016/0003-9861(83)90181-9"/>
<external-link type="pmpid" public-id="6404222"/>
</reference>
<reference id="b40" type="article" volume="60" first-page="6806" last-page="6812">
<reference-author first-name="A" last-name="Brandi"/>
<reference-author first-name="S" last-name="Cicchi"/>
<reference-author first-name="F" middle-names="M" last-name="Codero"/>
<reference-author first-name="B" last-name="Frignoli"/>
<reference-author first-name="A" last-name="Goti"/>
<reference-author first-name="S" last-name="Picasso"/>
<reference-author first-name="P" last-name="Vogel"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="1995"/>
<external-link type="doi" public-id="10.1021/jo00126a033"/>
</reference>
<copyright year="2005" holder="Andriuzzi et al; licensee Beilstein-Institut." link="http://creativecommons.org/licenses/by/2.0">
<paragraph>
<chunk>This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</chunk>
</paragraph>
<paragraph>
<chunk>The license is subject to the </chunk>
<chunk italic="yes">Beilstein Journal of Organic Chemistry</chunk>
<chunk> terms and conditions: (http://www.beilstein-journals.org/bjoc)</chunk>
</paragraph>
</copyright>
</article>
